Showing results (371-380 of 1,711) with videos related to

Sort By:
Pageof 172
Circulation. Heart Failure|July 3, 2023
Distinct Inflammatory Milieu in Patients With Right Heart FailureBin Q Yang, Arick C Park, Jason Liu, et al.
Circulation. Heart Failure|September 27, 2023
MMP-2 Associates With Incident Heart Failure and Atrial Fibrillation: The ARIC StudyLeo F Buckley, Ali M Agha, Pranav Dorbala, et al.
Circulation. Heart Failure|June 8, 2023
Cardiovascular Measures of All-Cause Mortality in Duchenne Muscular DystrophyJonathan H Soslow, Meng Xu, James C Slaughter, et al.
Circulation. Heart Failure|September 19, 2023
Common Variants on FGD5 Increase Hazard of Mortality or Rehospitalization in Patients With Heart Failure From the ASCEND-HF TrialHongsheng Gui, W H Wilson Tang, Stephan Francke, et al.
Circulation. Heart Failure|May 26, 2023
Sex-Associated Differences in the Clinical Outcomes of Left Ventricular Assist Device Recipients: Insights From Interagency Registry for Mechanically Assisted Circulatory SupportNaman S Shetty, Vibhu Parcha, Peter Abdelmessih, et al.
Circulation. Heart Failure|February 24, 2026
Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac AmyloidosisMattia Zampieri, Giulia Biagioni, Annamaria Del Franco, et al.
Circulation. Heart Failure|February 23, 2026
Mitigating Risk of Kidney Dysfunction After Heart Transplantation and Therapeutic ApproachesErsilia M DeFilippis, Richard K Cheng, Elena M Donald, et al.
Circulation. Heart Failure|February 23, 2026
Invasive Hemodynamic Exercise Response in Hemodynamically Significant Aortic Stenosis With Preserved Left Ventricular Ejection FractionMulham Ali, Peter Hartmund Frederiksen, Jacob Eifer Møller, et al.
Circulation. Heart Failure|March 25, 2026
Mechanisms of GLP-1 Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic BenefitJordyn Thomas, Misha Dagan, Bing Wang, et al.
Circulation. Heart Failure|May 9, 2026
Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid CardiomyopathyAhmad Masri, Francesco Cappelli, Margot K Davis, et al.
Pageof 172